Adjuvant checkpoint inhibitor trials: Is disease-free survival an appropriate endpoint?

被引：0
|
作者：
Khaki, Ali Raza [1 ,4 ]
Lythgoe, Mark P. [2 ]
Prasad, Vinay [3 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Imperial Coll London, London, England
[3] Univ Calif San Francisco, San Francisco, CA USA
[4] Stanford Univ, Sch Med, Clin E, 875 Blake Wilbur Dr, Stanford, CA 94305 USA
来源：
JOURNAL OF CANCER POLICY | 2023年 / 35卷
关键词：
ONCOLOGY;
D O I：
10.1016/j.jcpo.2023.100402
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer
    Pusztai, Lajos
    Broglio, Kristine
    Andre, Fabrice
    Symmans, W. Fraser
    Hess, Kenneth R.
    Hortobagyi, Gabriel N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) : 4679 - 4683
  • [22] Disease-free survival (OFS) vs. overall survival (OS) as a primary endpoint for adjuvant colon cancer studies: Individual patient data from 12,915 patients on 15 randomized trials.
    Sargent, DJ
    Wieand, S
    Benedetti, J
    Labianca, R
    Haller, DG
    Shepherd, LE
    Seitz, JF
    Francini, G
    De Gramont, A
    Goldberg, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 245S - 245S
  • [23] Impact on overall survival and disease-free survival of adjuvant chemotherapy after neoadjuvant chemoradiotherapy for rectal cancer
    de Castro, Rafael Amaral
    Paiva, Carlos Eduardo
    Saad-Hossne, Rogerio
    Michelin, Odair Carlito
    Souza, Cristiano de Padua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Disease-free survival in head and neck cancer patients with and without adjuvant mistletoe treatment
    Steuer-Vogt, MK
    Bonkowsky, V
    Ambrosch, P
    Scholz, M
    Strutz, J
    Lenarz, T
    Arnold, W
    4TH EUROPEAN CONGRESS OF OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, VOLS 1 AND 2, 2000, : 755 - 758
  • [25] IMPROVEMENT OF DISEASE-FREE AND OVERALL SURVIVAL BY ADJUVANT CMF IN OPERABLE BREAST-CANCER
    BONADONNA, G
    VALAGUSSA, P
    ROSSI, A
    VERONESI, U
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 215 - 215
  • [26] Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy
    Kalapurakal, JA
    Huang, CF
    Neriamparampil, MM
    Small, WJ
    Pins, MR
    Mittal, BB
    Campbell, SC
    Grayhack, JT
    Shetty, RM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (04): : 1047 - 1054
  • [27] Adjuvant interferon α in high risk resected melanoma appears to prolong disease-free survival
    Cameron, DA
    Cornbleet, MC
    Mackie, RM
    Hunter, JAA
    Hancock, B
    Gore, M
    Smyth, JF
    BRITISH JOURNAL OF CANCER, 2000, 83 : 61 - 61
  • [28] Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer
    Fangchao Zheng
    Tong Wei
    Xue Wang
    Feng Du
    Jian Yue
    Peng Yuan
    Experimental Hematology & Oncology, 11
  • [29] Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer
    Zheng, Fangchao
    Wei, Tong
    Wang, Xue
    Du, Feng
    Yue, Jian
    Yuan, Peng
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [30] PROLONGED DISEASE-FREE SURVIVAL IN DIABETICS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1981, 282 (6273): : 1339 - 1340
12345